Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this early feasibility study was to investigate the pharmacokinetics of
MP-3180 administered in rising doses and to evaluate the use of the Optical Renal Function
Monitor (ORFM), an investigational noninvasive fluorescence detection device.